The Biotech Industry faces unique challenges:

Innovators are often very small privatly funded companies with significant technical expertise,
but limited resources to commercialize and bring products to market.
GB5D helps these companies think through a strategic commercialization plan while still in the development phase.
Even though most of our customers hope to be acquired before having to commercialize the products,
having a solid and credible plan, that can be implemented when needed,
helps the company position itself for a higher valuation,
or grow organically should they remain independent.